亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

頭孢氨芐 CAS:15686-71-2

 
 
單價(jià) 面議對(duì)比
詢價(jià) 暫無(wú)
發(fā)貨 湖北隨州市付款后3天內(nèi)
型號(hào) 15686-71-2
過(guò)期 長(zhǎng)期有效
更新 2020-07-28 08:59
 

隨州市紅旗化工有限公司

企業(yè)會(huì)員第15年
資料未認(rèn)證
保證金未繳納
  • 湖北-隨州市
  • 上次登錄 2023-06-07
  • 閆先生 (先生)   經(jīng)理
詳細(xì)說(shuō)明
頭孢氨芐
CAS:15686-71-2
英文名稱:Cephalexin
中文別名:苯甘頭孢霉素;頭孢立新;先鋒霉素Ⅳ;頭孢菌素Ⅳ;(6R,7R)-3-甲基-7-((R)-2-氨基-2-苯乙酰氨基)-8-氧-5-硫雜-1-雙環(huán)(4.2.0)辛-2-烯-2-甲酸
EINECS號(hào): 239-773-6
分子式: C16H17N3O4S
分子量: 347.39
標(biāo)準(zhǔn):cp2005
含量:≥95%
性狀:白色至微黃色結(jié)晶粉末
用途:該品是第一個(gè)合成的口服頭孢菌素,對(duì)酸、青霉素酶均穩(wěn)定。其抗菌機(jī)理、抗菌譜和適應(yīng)癥均與頭孢噻吩相似,但抗菌強(qiáng)度弱于后者和頭孢噻吩,用于較輕感染。
包裝:25kg/桶
舉報(bào)收藏 0評(píng)論 0
更多>本企業(yè)其它產(chǎn)品
來(lái)氟米特 CAS號(hào): 75706-12-6 頭孢曲松鈉 CAS;74578-69-1 福多斯坦 CAS號(hào): 13189-98-5 克洛索隆 CAS;60200-06-8 磷酸吡哆醛 CAS號(hào): 54-47-7 4-甲基噻唑-5-甲醛 CAS號(hào): 82294-70-0 三氯苯噠唑 CAS:68786-66-3 5-乙酰水楊酸甲酯 CAS;16475-90-4
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |